- Home
- AKRO vs CRTO Comparison
AKRO vs CRTO Comparison
Compare AKRO & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- CRTO
- Stock Information
- Founded
- AKRO 2017
- CRTO 2005
- Country
- AKRO United States
- CRTO France
- Employees
- AKRO N/A
- CRTO N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- CRTO Advertising
- Sector
- AKRO Health Care
- CRTO Consumer Discretionary
- Exchange
- AKRO Nasdaq
- CRTO Nasdaq
- Market Cap
- AKRO 2.8B
- CRTO 2.1B
- IPO Year
- AKRO 2019
- CRTO 2013
- Fundamental
- Price
- AKRO $37.63
- CRTO $29.90
- Analyst Decision
- AKRO Strong Buy
- CRTO Buy
- Analyst Count
- AKRO 9
- CRTO 10
- Target Price
- AKRO $76.29
- CRTO $53.00
- AVG Volume (30 Days)
- AKRO 1.3M
- CRTO 359.3K
- Earning Date
- AKRO 05-09-2025
- CRTO 05-02-2025
- Dividend Yield
- AKRO N/A
- CRTO N/A
- EPS Growth
- AKRO N/A
- CRTO 115.91
- EPS
- AKRO N/A
- CRTO 1.90
- Revenue
- AKRO N/A
- CRTO $1,933,289,000.00
- Revenue This Year
- AKRO N/A
- CRTO N/A
- Revenue Next Year
- AKRO N/A
- CRTO $7.76
- P/E Ratio
- AKRO N/A
- CRTO $15.74
- Revenue Growth
- AKRO N/A
- CRTO N/A
- 52 Week Low
- AKRO $17.86
- CRTO $27.46
- 52 Week High
- AKRO $58.40
- CRTO $49.93
- Technical
- Relative Strength Index (RSI)
- AKRO 43.61
- CRTO 39.29
- Support Level
- AKRO $36.46
- CRTO $27.46
- Resistance Level
- AKRO $39.13
- CRTO $32.27
- Average True Range (ATR)
- AKRO 3.04
- CRTO 2.03
- MACD
- AKRO 0.06
- CRTO -0.12
- Stochastic Oscillator
- AKRO 57.38
- CRTO 28.37
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.